AR and metastatic prostate carcinoma: Interestingly, the treatment with betulinic acid of the transgenic TRAP mice model of metastatic prostate cancer resulted in tumor growth inhibition and apoptosis mediated by caspase-3 activation and downregulation of the androgen receptor [18].